https://www.selleckchem.com/products/lly-283.html
Baseline mean forced vital capacity (FVC) was 74±22% predicted. Median duration of follow-up was 46.2 months. Annualised FVC decline during the first year was estimated at 136±328 mL using a linear mixed model. Overall survival was 83% at 3 years and 72% at 5 years. Using multivariate Cox regression analysis, mortality was significantly associated with relative FVC decline ≥10% in the previous 24 months (p less then 0.05), age ≥50 years (p less then 0.01) and diagnosis subgroup (p less then 0.01).In this cohort of patients with PF-ILD n